These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27951451)

  • 1. Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.
    Sampaio LRL; Borges LTN; Barbosa TM; Matos NCB; Lima RF; Oliveira MN; Gularte VN; Patrocínio MCA; Macêdo D; Vale OCD; Vasconcelos SMM
    J Psychiatr Res; 2017 Mar; 86():73-82. PubMed ID: 27951451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
    Sampaio LRL; Cysne Filho FMS; de Almeida JC; Diniz DDS; Patrocínio CFV; de Sousa CNS; Patrocínio MCA; Macêdo D; Vasconcelos SMM
    Neuroscience; 2018 Mar; 373():72-81. PubMed ID: 29337238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine.
    Sampaio LRL; Borges LTN; Silva JMF; de Andrade FRO; Barbosa TM; Oliveira TQ; Macedo D; Lima RF; Dantas LP; Patrocinio MCA; do Vale OC; Vasconcelos SMM
    Fundam Clin Pharmacol; 2018 Feb; 32(1):60-68. PubMed ID: 28853229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.
    Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis.
    Della Giustina A; Goldim MP; Danielski LG; Florentino D; Mathias K; Garbossa L; Oliveira Junior AN; Fileti ME; Zarbato GF; da Rosa N; Martins Laurentino AO; Fortunato JJ; Mina F; Bellettini-Santos T; Budni J; Barichello T; Dal-Pizzol F; Petronilho F
    Neurochem Int; 2017 Sep; 108():436-447. PubMed ID: 28606823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
    Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase.
    Canever L; Freire TG; Mastella GA; Damázio L; Gomes S; Fachim I; Michels C; Carvalho G; Godói AK; Peterle BR; Gava FF; Valvassori SS; Budni J; Quevedo J; Zugno AI
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():52-64. PubMed ID: 29782958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
    Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
    Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia.
    Becker A; Peters B; Schroeder H; Mann T; Huether G; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):687-700. PubMed ID: 12787858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
    Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J
    Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.
    Damazio LS; Silveira FR; Canever L; Castro AA; Estrela JM; Budni J; Zugno AI
    An Acad Bras Cienc; 2017; 89(2):1133-1141. PubMed ID: 28513779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
    Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
    Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes.
    Lewine JD; Weber W; Gigliotti A; McDonald JD; Doyle-Eisele M; Bangera N; Paulson K; Magcalas C; Hamilton DA; Garcia E; Raulli R; Laney J
    Neurotoxicology; 2018 Dec; 69():37-46. PubMed ID: 30172622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats.
    Kozela E; Krawczyk M; Kos T; Juknat A; Vogel Z; Popik P
    Mol Neurobiol; 2020 Mar; 57(3):1733-1747. PubMed ID: 31823199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.